These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2120444

  • 1. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S.
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    Johansson AM, Karlén A, Grol CJ, Sundell S, Kenne L, Hacksell U.
    Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
    [Abstract] [Full Text] [Related]

  • 3. Derivatives of 2-(dipropylamino)tetralin: effect of the C8-substituent on the interaction with 5-HT1A receptors.
    Liu Y, Yu H, Svensson BE, Cortizo L, Lewander T, Hacksell U.
    J Med Chem; 1993 Dec 24; 36(26):4221-9. PubMed ID: 7506312
    [Abstract] [Full Text] [Related]

  • 4. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
    Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U.
    J Neural Transm; 1986 Dec 24; 65(1):1-27. PubMed ID: 3083041
    [Abstract] [Full Text] [Related]

  • 5. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B.
    J Med Chem; 1985 Aug 24; 28(8):1049-53. PubMed ID: 3927002
    [Abstract] [Full Text] [Related]

  • 6. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L, Höök BB, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1989 Apr 24; 32(4):779-83. PubMed ID: 2522991
    [Abstract] [Full Text] [Related]

  • 7. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L.
    J Med Chem; 1987 Oct 24; 30(10):1827-37. PubMed ID: 3656358
    [Abstract] [Full Text] [Related]

  • 8. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug 24; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 9. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
    Liu Y, Mellin C, Björk L, Svensson B, Csöregh I, Helander A, Kenne L, Andén NE, Hacksell U.
    J Med Chem; 1989 Oct 24; 32(10):2311-8. PubMed ID: 2795604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun 24; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov 24; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 17. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S.
    J Med Chem; 1987 Jul 24; 30(7):1135-44. PubMed ID: 3599021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C, Vallgårda J, Nelson DL, Björk L, Yu H, Andén NE, Csöregh I, Arvidsson LE, Hacksell U.
    J Med Chem; 1991 Feb 24; 34(2):497-510. PubMed ID: 1995871
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.